Pharma companies and CROs are recognizing the need for focused electronic feasibility solutions to resolve challenges with processes managed in Excel trackers.
Overcoming the many known barriers to adopting and implementing an RBM program.
This whitepaper offers a résumé of regulations under which eConsent solutions and vendors may fall and, more importantly, discusses the practical implications of those regulations for vendors and those responsible for designing and executing research plans.
As more and more sites adopt eSource, the industry is poised for swift change and dramatic growth.
With the FDA mandate for WHODrug B3/C3 less than a year away you have to consider if your coding solution and data capture system(s) are up to the task.
Study start-up delays have perplexed the best minds in the clinical trials industry for decades. Discover how advanced analytics and an intense focus on the four problem areas can help.
A strategy to reduce potential conflicts when working with clinical research study stakeholders.
Three essential things for data managers to look for - and for technology providers like us to deliver - as clinical trial technology becomes more prevalent and diverse.
|
|
|
|
|
|
|
|
|